About
Small Molecule
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
379
By Phase
PHASE2: 5PHASE1: 2PHASE1/PHASE2: 3
By Status
COMPLETED: 6TERMINATED: 3RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06568692Lead Sponsor
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
PHASE2Recruiting
90 participants
Started: Oct 2, 2024 · Completed: Oct 31, 2026
NCT05270460Lead Sponsor
Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis
PHASE2Completed
25 participants
Started: Mar 9, 2022 · Completed: Oct 6, 2022
NCT04861987Lead Sponsor
A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors
PHASE1Completed
23 participants
Started: Jun 18, 2021 · Completed: Sep 9, 2024
NCT04800562Lead Sponsor
A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica
PHASE2Terminated
4 participants
Started: Apr 12, 2021 · Completed: Apr 14, 2023
NCT03698864Lead Sponsor
A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica
PHASE2Completed
12 participants
Started: Nov 7, 2018 · Completed: Feb 25, 2020
Locations (1)
Headquarters
Hanover, MD, United States
Map
Loading map...